CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

Ana Salazar Modela Tu Cuerpo Inc. Issues Nationwide Voluntary Recall of Lipofit Extreme Fat Burner 2.0 Due to Presence of Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)

RegulatoryrejectedLipofit Extreme Fat Burner 2.0Negative
AI Analysis

Summary

Ana Salazar Modela Tu Cuerpo Inc. issued a nationwide voluntary recall of Lipofit Extreme Fat Burner 2.0 after FDA laboratory analysis detected undeclared fluoxetine and 2,4-dinitrophenol (DNP) in the product.

Outcome Details

Nationwide voluntary recall due to presence of undeclared Fluoxetine and 2,4-Dinitrophenol (DNP) found by FDA laboratory analysis. Lot 25M12F, expiration date 09/2027.

Importance:4/10
Sentiment:
-0.95
product recallundeclared ingredientsFDA enforcementconsumer safetydietary supplement

Read the original article

Published by FDA Drugs (New Approvals & NDA) on August 31, 2026 2:54 PM

Read Original